Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's proprietary portfolio includes around six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of t... Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's proprietary portfolio includes around six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. 더 보기
Submitted New Drug Application (NDA) for taletrectinib to the U.S. Food and Drug Administration (FDA) in October for the treatment of patients with advanced ROS1-positive (ROS1+) non-small cell...
Global leader with proven financial, operational, and commercial expertise joins Nuvation Bio as the company prepares to transition into a commercial-stage organization Nuvation Bio Inc. (NYSE:...
Tumors shrank in 89% of taletrectinib-treated patients with advanced ROS1-positive (ROS1+) non-small cell lung cancer (NSCLC) who were tyrosine kinase inhibitor (TKI)-naïve and 56% of those who...
Nuvation Bio Inc. (NYSE: NUVB), a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced that David Hung, M.D., Founder...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.56 | 24.2424242424 | 2.31 | 2.98 | 2.18 | 1777246 | 2.35419605 | CS |
4 | 0.71 | 32.8703703704 | 2.16 | 2.98 | 2 | 1560311 | 2.33720763 | CS |
12 | 0.06 | 2.13523131673 | 2.81 | 3.3986 | 2 | 1550974 | 2.60363083 | CS |
26 | -0.32 | -10.0313479624 | 3.19 | 3.97 | 2 | 1522467 | 2.88246219 | CS |
52 | 1.54 | 115.789473684 | 1.33 | 4.1598 | 1.21 | 1334329 | 2.64763358 | CS |
156 | -6.33 | -68.8043478261 | 9.2 | 10.45 | 0.95 | 1016106 | 3.16198346 | CS |
260 | -7.13 | -71.3 | 10 | 15.23 | 0.95 | 971720 | 4.41210972 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관